BRPI0015061B8 - comprimido revestido tendo alta dosagem de cloridrato de sevelamer - Google Patents
comprimido revestido tendo alta dosagem de cloridrato de sevelamerInfo
- Publication number
- BRPI0015061B8 BRPI0015061B8 BRPI0015061A BR0015061A BRPI0015061B8 BR PI0015061 B8 BRPI0015061 B8 BR PI0015061B8 BR PI0015061 A BRPI0015061 A BR PI0015061A BR 0015061 A BR0015061 A BR 0015061A BR PI0015061 B8 BRPI0015061 B8 BR PI0015061B8
- Authority
- BR
- Brazil
- Prior art keywords
- tablet core
- aliphatic amine
- amine polymer
- polymer
- weight
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16025899P | 1999-10-19 | 1999-10-19 | |
US17422700P | 2000-01-03 | 2000-01-03 | |
PCT/US2000/028548 WO2001028527A2 (en) | 1999-10-19 | 2000-10-13 | Direct compression polymer tablet core |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0015061A BR0015061A (pt) | 2002-07-23 |
BRPI0015061B1 BRPI0015061B1 (pt) | 2016-03-22 |
BRPI0015061B8 true BRPI0015061B8 (pt) | 2021-05-25 |
Family
ID=26856737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0015061A BRPI0015061B8 (pt) | 1999-10-19 | 2000-10-13 | comprimido revestido tendo alta dosagem de cloridrato de sevelamer |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1239837B1 (pt) |
JP (4) | JP4942271B2 (pt) |
KR (1) | KR100794427B1 (pt) |
CN (1) | CN1202812C (pt) |
AR (1) | AR026067A1 (pt) |
AT (1) | ATE286386T1 (pt) |
AU (1) | AU778262B2 (pt) |
BG (1) | BG106626A (pt) |
BR (1) | BRPI0015061B8 (pt) |
CA (1) | CA2387915C (pt) |
CZ (1) | CZ20021344A3 (pt) |
DE (1) | DE60017285T2 (pt) |
EA (1) | EA200200387A1 (pt) |
EE (1) | EE200200209A (pt) |
ES (1) | ES2235969T3 (pt) |
HK (1) | HK1049451B (pt) |
HU (1) | HUP0203334A2 (pt) |
IL (1) | IL149146A0 (pt) |
IS (1) | IS6343A (pt) |
MX (1) | MXPA02003684A (pt) |
MY (1) | MY125495A (pt) |
NO (1) | NO20021827L (pt) |
NZ (1) | NZ518334A (pt) |
PL (1) | PL364888A1 (pt) |
PT (1) | PT1239837E (pt) |
SK (1) | SK5412002A3 (pt) |
TR (1) | TR200201087T2 (pt) |
TW (1) | TWI225413B (pt) |
WO (1) | WO2001028527A2 (pt) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1202812C (zh) * | 1999-10-19 | 2005-05-25 | 基酶有限公司 | 直接压缩聚合物片剂核 |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7608674B2 (en) | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
WO2005065291A2 (en) * | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
DE602005018619D1 (de) | 2004-03-30 | 2010-02-11 | Relypsa Inc | Ionenbindende zusammensetzungen |
AU2012200480B2 (en) * | 2004-11-01 | 2014-10-16 | Genzyme Corporation | "Aliphatic amine polymer salts for tableting" |
US7985418B2 (en) * | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
AU2006227429A1 (en) * | 2005-03-17 | 2006-09-28 | Amgen Inc. | Methods of decreasing calcification |
CA2620406A1 (en) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
ES2556217T3 (es) * | 2005-09-15 | 2016-01-14 | Genzyme Corporation | Formulación en bolsa para polímeros de amina |
EP2441779A1 (en) * | 2006-09-01 | 2012-04-18 | USV Limited | Process for the preparation of sevelamer hydrochloride and formulation thereof |
JP2010504975A (ja) | 2006-09-29 | 2010-02-18 | ゲンズイメ コーポレーション | アミドデンドリマー組成物 |
JP2010513271A (ja) | 2006-12-14 | 2010-04-30 | ゲンズイメ コーポレーション | アミド−アミンポリマー組成物 |
WO2009034540A1 (en) * | 2007-09-11 | 2009-03-19 | Ranbaxy Laboratories Limited | Pharmaceutical composition of sevelamer |
DE102008030046A1 (de) * | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
WO2010041268A2 (en) | 2008-09-02 | 2010-04-15 | Usv Limited | Crosslinked polymers |
US20100330175A1 (en) * | 2009-06-24 | 2010-12-30 | Jobdevairakkam Christopher N | Cross-linked polyallylamine tablet core |
WO2010149794A2 (en) * | 2009-06-26 | 2010-12-29 | Combino Pharm, S.L. | Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane) |
ES2350999B1 (es) * | 2009-06-26 | 2011-12-07 | Combino Pharm, S.L. | Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano). |
ES2720869T3 (es) * | 2009-10-22 | 2019-07-25 | Synthon Bv | Composiciones farmacéuticas de sevelámero |
EP2545907A1 (en) | 2011-07-15 | 2013-01-16 | Combino Pharm, S.L. | Aqueous wet granulation process for cross-linked polyallylamine polymers |
US9693962B2 (en) * | 2012-06-05 | 2017-07-04 | Takeda Pharmaceutical Limited | Dry-coated tablet |
CN102908325B (zh) * | 2012-11-12 | 2014-07-30 | 南京生命能科技开发有限公司 | 一种碳酸司维拉姆药用片剂组合物及其制备方法 |
CN107412166B (zh) * | 2017-08-08 | 2020-03-24 | 同济大学 | 一种纳米复合吸附磷材料及其制备与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU222242B1 (hu) * | 1991-07-03 | 2003-05-28 | Pharmacia & Upjohn Co. | Kolesztipol-hidroklorid tabletta és eljárás annak előállítására |
US5496545A (en) * | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
JP3389493B2 (ja) * | 1997-04-04 | 2003-03-24 | 中外製薬株式会社 | リン酸結合性ポリマー製剤 |
TW592727B (en) * | 1997-04-04 | 2004-06-21 | Chugai Pharmaceutical Co Ltd | Phosphate-binding polymer preparations |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
TW568788B (en) * | 1998-10-12 | 2004-01-01 | Chugai Pharmaceutical Co Ltd | Polymer combining with phosphoric acid and preparation containing the same |
CN1202812C (zh) * | 1999-10-19 | 2005-05-25 | 基酶有限公司 | 直接压缩聚合物片剂核 |
-
2000
- 2000-10-13 CN CNB008146071A patent/CN1202812C/zh not_active Expired - Lifetime
- 2000-10-13 DE DE60017285T patent/DE60017285T2/de not_active Expired - Lifetime
- 2000-10-13 SK SK541-2002A patent/SK5412002A3/sk unknown
- 2000-10-13 IL IL14914600A patent/IL149146A0/xx unknown
- 2000-10-13 PL PL00364888A patent/PL364888A1/xx unknown
- 2000-10-13 MX MXPA02003684A patent/MXPA02003684A/es active IP Right Grant
- 2000-10-13 AU AU10887/01A patent/AU778262B2/en not_active Expired
- 2000-10-13 EE EEP200200209A patent/EE200200209A/xx unknown
- 2000-10-13 TR TR2002/01087T patent/TR200201087T2/xx unknown
- 2000-10-13 ES ES00972191T patent/ES2235969T3/es not_active Expired - Lifetime
- 2000-10-13 NZ NZ518334A patent/NZ518334A/en not_active IP Right Cessation
- 2000-10-13 HU HU0203334A patent/HUP0203334A2/hu unknown
- 2000-10-13 CA CA002387915A patent/CA2387915C/en not_active Expired - Fee Related
- 2000-10-13 PT PT00972191T patent/PT1239837E/pt unknown
- 2000-10-13 WO PCT/US2000/028548 patent/WO2001028527A2/en active IP Right Grant
- 2000-10-13 CZ CZ20021344A patent/CZ20021344A3/cs unknown
- 2000-10-13 BR BRPI0015061A patent/BRPI0015061B8/pt not_active IP Right Cessation
- 2000-10-13 KR KR1020027005018A patent/KR100794427B1/ko active IP Right Grant
- 2000-10-13 JP JP2001531357A patent/JP4942271B2/ja not_active Expired - Lifetime
- 2000-10-13 EA EA200200387A patent/EA200200387A1/ru unknown
- 2000-10-13 AT AT00972191T patent/ATE286386T1/de active
- 2000-10-13 EP EP00972191A patent/EP1239837B1/en not_active Expired - Lifetime
- 2000-10-17 TW TW089121646A patent/TWI225413B/zh not_active IP Right Cessation
- 2000-10-18 AR ARP000105456A patent/AR026067A1/es unknown
- 2000-10-18 MY MYPI20004885A patent/MY125495A/en unknown
-
2002
- 2002-04-15 IS IS6343A patent/IS6343A/is unknown
- 2002-04-18 NO NO20021827A patent/NO20021827L/no not_active Application Discontinuation
- 2002-04-19 BG BG106626A patent/BG106626A/bg unknown
-
2003
- 2003-03-06 HK HK03101656.0A patent/HK1049451B/zh not_active IP Right Cessation
-
2011
- 2011-12-29 JP JP2011290234A patent/JP5583110B2/ja not_active Expired - Lifetime
-
2014
- 2014-01-21 JP JP2014008451A patent/JP5903111B2/ja not_active Expired - Lifetime
-
2015
- 2015-09-03 JP JP2015173635A patent/JP2016000753A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0015061B8 (pt) | comprimido revestido tendo alta dosagem de cloridrato de sevelamer | |
BRPI0316532B8 (pt) | composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável | |
MXPA05001061A (es) | Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol. | |
DE122004000032I2 (de) | Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung | |
BR0013720A (pt) | Formulação em pelota de liberação controlada | |
IT1288290B1 (it) | Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie | |
BR9714739A (pt) | Composição farmacêutica para reduzir a depressão respiratória e os efeitos colaterais inerentes de compostos opióides mu | |
PT1073470E (pt) | Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos | |
BR0113608A (pt) | Composição cosmética clara em emulsão antiperspirante e/ou desodorante | |
ATE489099T1 (de) | Aminozucker, chondroitin und s-adenosylmethionin enthaltende zusammensetzungen | |
BR0109150A (pt) | Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente | |
BRPI0615860B8 (pt) | composição farmacêutica de liberação prolongada monolítica sólida | |
BR9806801A (pt) | Utilização de um antagonista de receptores cb1, composição farmacêutica, e, estojo para o tratamento de distúrbios da apetência | |
NO964213D0 (no) | Forbedret anti-flass shampo | |
BR9406363A (pt) | Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico | |
KR930005617A (ko) | 트라마돌 및 코데인, 옥시코돈 또는 하이드로코돈을 함유하는 조성물 및 그의 용도 | |
BR9913400A (pt) | Formulação oral de liberação imediata na forma sólida de um inibidor de trombina, uso de um inibidor de trombina baseado em peptìdeo de baixo peso molecular, processos para a profilaxia e/ou o tratamento de trombo-embolismo, e para a preparação de uma formulação oral de liberação imediata, e, uso de uma carga escolhida do grupo consistindo de um derivado de celulose, e um derivado de amido | |
ATE375729T1 (de) | Verfahren zur herstellung eines pharmazeutischen kaugummis | |
HK1084015A1 (en) | Stable pharmaceutical compositions of 2-aza-bicyclo3.3.0 -octane-3- carboxylic acid derivatives 2- | |
BR0107371A (pt) | Formulação de inìcio rápido | |
BR9814764A (pt) | Composição aquosa, uso da mesma, e, substrato. | |
RS4204A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
BR0207827A (pt) | Método de preparação de uma micropartìcula homogênea que compreende um inibidor de h+/k+-atpase ácido lábil, micropartìcula, composição farmacêutica, método para prevenir ou tratar uma doença relacionada com o ácido gástrico em um mamìfero, e, uso de uma micropartìcula | |
BR0107958A (pt) | Composição farmacêutica contendo pemetrexado juntamente com l-cisteìna monotrioglicerol ou ácido tioglicólico | |
BR9914155A (pt) | Composições curáveis de revestimento contendo combinações de compostos funcionais de carbamato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: GENZYME CORPORATION (US) Free format text: TRANSFERIDO DE: GELTEX PHARMACEUTICALS, INC. |
|
B25G | Requested change of headquarter approved |
Owner name: GENZYME CORPORATION (US) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 018080029522/SP DE 14/05/2008. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 9/20 Ipc: A61K 31/785 (2009.01), A61K 9/28 (2009.01), A61K 3 |
|
B15V | Prolongation of time limit allowed |
Free format text: DEVOLUCAO DE PRAZO CONCEDIDA - RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 19 DIAS, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 22/03/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/10/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 13/10/2020 |